Therapeutic Asset Ratings

567 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Nivolumab Skin Basal Cell Carcinoma	Fred Hutchinson Cancer Center	P2	B (63)
Nivolumab Skin Squamous Cell Carcinoma	Fred Hutchinson Cancer Center	P2	B (63)
Polyiclc Clinical Stage IV Cutaneous Melanoma AJCC v8	Fred Hutchinson Cancer Center	P2	B (63)
Zofran T-cell Lymphoma	Fred Hutchinson Cancer Center	P2	B (63)
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P2/3	B (63)
Evomela Relapsed/Refractory Diffuse Large B-Cell Lymphoma	Fred Hutchinson Cancer Center	P3	B (62)
Fludarabine Mixed Phenotype Acute Leukemia	Fred Hutchinson Cancer Center	P3	B (62)
Irinotecan Prostate Cancer	Fred Hutchinson Cancer Center	P3	B (62)
METHOTREXATE Chronic Myelomonocytic Leukemia	Fred Hutchinson Cancer Center	P3	B (62)
Monomethyl Fumarate Mixed Phenotype Acute Leukemia	Fred Hutchinson Cancer Center	P3	B (62)
(+)-VINCRISTINE Prostate Cancer	Fred Hutchinson Cancer Center	P3	B (62)
METHOTREXATE Myelodysplastic Syndrome With Excess Blasts-1	Fred Hutchinson Cancer Center	P2	B (62)
METHOTREXATE Paroxysmal Nocturnal Hemoglobinuria	Fred Hutchinson Cancer Center	P2	B (62)
METHOTREXATE Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	B (62)
Nivolumab Acral Lentiginous Melanoma	Fred Hutchinson Cancer Center	P2	B (62)
Nivolumab Mucosal Melanoma	Fred Hutchinson Cancer Center	P2	B (62)
Polyiclc Mucosal Melanoma	Fred Hutchinson Cancer Center	P2	B (62)
Thiotepa Acute Undifferentiated Leukemia	Fred Hutchinson Cancer Center	P2	B (62)
Thiotepa Myelodysplastic Syndrome With Excess Blasts-1	Fred Hutchinson Cancer Center	P2	B (62)
Treosulfan Bone Marrow Failure Syndrome	Fred Hutchinson Cancer Center	P2	B (62)
Treosulfan Chronic Myeloid Leukemia	Fred Hutchinson Cancer Center	P2	B (62)
Anti-Thymoglobulin, Rabbit Myelofibrosis	Fred Hutchinson Cancer Center	P2/3	B (62)
Cyclophosphamide Metastatic Bladder Giant Cell Urothelial Carcinoma	Fred Hutchinson Cancer Center	P2/3	B (62)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4) Infiltrating Bladder Urothelial Carcinoma	Fred Hutchinson Cancer Center	P2/3	B (62)
Epirubicin Metastatic Bladder Giant Cell Urothelial Carcinoma	Fred Hutchinson Cancer Center	P2/3	B (62)

Showing 151 to 175 of 567 assets

PreviousPage 7 of 23Next